Noseguard for Prevention of Respiratory Infections in Real-World Use

Starting soon · Not applicable

Conditions studied: Respiratory Infection Virus, COVID-19, Influenza

In brief

This study is a prospective clinical study to evaluate the effectiveness of combined use of two nasal protective medical devices (Noseguard and Noseguard Night) in reducing respiratory infection rates, including COVID-19 and influenza, in real-world conditions. The study will also assess usability, satisfaction, and safety using electronic patient-reported outcomes (ePRO).

Key facts

Study ID

NCT07516977

Run by

Daewoong Pharmaceutical Co. LTD.

People needed

2000

Starts

2026-04-20

Expected to finish

2026-12-31

Last updated by the study team

2026-04-08

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged ≥19 years
• Able to provide informed consent

You may not qualify if…

• Hypersensitivity to device components
• Current COVID-19 or influenza infection
• Severe nasal disease
• Pregnant or breastfeeding women

Where it is running

• Jeonbuk University Hospital — Jeonju, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.